These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 15840407)

  • 21. Androgens potentiate renal vascular responses to angiotensin II via amplification of the Rho kinase signaling pathway.
    Song J; Kost CK; Martin DS
    Cardiovasc Res; 2006 Dec; 72(3):456-63. PubMed ID: 17049502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of fasudil on early atherosclerotic plaque formation and established lesion progression in apolipoprotein E-knockout mice.
    Wu DJ; Xu JZ; Wu YJ; Jean-Charles L; Xiao B; Gao PJ; Zhu DL
    Atherosclerosis; 2009 Nov; 207(1):68-73. PubMed ID: 19473657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 attenuates angiotensin II/salt-induced aortic remodeling.
    Weisberg AD; Albornoz F; Griffin JP; Crandall DL; Elokdah H; Fogo AB; Vaughan DE; Brown NJ
    Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):365-71. PubMed ID: 15576638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heparin cofactor II protects against angiotensin II-induced cardiac remodeling via attenuation of oxidative stress in mice.
    Sumitomo-Ueda Y; Aihara K; Ise T; Yoshida S; Ikeda Y; Uemoto R; Yagi S; Iwase T; Ishikawa K; Hirata Y; Akaike M; Sata M; Kato S; Matsumoto T
    Hypertension; 2010 Sep; 56(3):430-6. PubMed ID: 20660821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelial nitric oxide synthase-independent protective action of statin against angiotensin II-induced atrial remodeling via reduced oxidant injury.
    Yagi S; Akaike M; Aihara K; Ishikawa K; Iwase T; Ikeda Y; Soeki T; Yoshida S; Sumitomo-Ueda Y; Matsumoto T; Sata M
    Hypertension; 2010 Apr; 55(4):918-23. PubMed ID: 20194307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blockade of NF-kappaB ameliorates myocardial hypertrophy in response to chronic infusion of angiotensin II.
    Kawano S; Kubota T; Monden Y; Kawamura N; Tsutsui H; Takeshita A; Sunagawa K
    Cardiovasc Res; 2005 Sep; 67(4):689-98. PubMed ID: 15921667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term inhibition of Rho-kinase ameliorates hypoxia-induced pulmonary hypertension in mice.
    Abe K; Tawara S; Oi K; Hizume T; Uwatoku T; Fukumoto Y; Kaibuchi K; Shimokawa H
    J Cardiovasc Pharmacol; 2006 Dec; 48(6):280-5. PubMed ID: 17204906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction.
    Zhong J; Basu R; Guo D; Chow FL; Byrns S; Schuster M; Loibner H; Wang XH; Penninger JM; Kassiri Z; Oudit GY
    Circulation; 2010 Aug; 122(7):717-28, 18 p following 728. PubMed ID: 20679547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of rho-kinase inhibitor on cardiac hypertrophy of left ventricle in spontaneously hypertensive rats].
    Zhang ZJ; Fan YF; Zhang ZY; Xie PY; Fang HC; Su YS
    Zhonghua Yi Xue Za Zhi; 2012 Dec; 92(48):3438-41. PubMed ID: 23327708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osteopontin modulates angiotensin II-induced fibrosis in the intact murine heart.
    Collins AR; Schnee J; Wang W; Kim S; Fishbein MC; Bruemmer D; Law RE; Nicholas S; Ross RS; Hsueh WA
    J Am Coll Cardiol; 2004 May; 43(9):1698-705. PubMed ID: 15120833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term treatment with a specific Rho-kinase inhibitor suppresses cardiac allograft vasculopathy in mice.
    Hattori T; Shimokawa H; Higashi M; Hiroki J; Mukai Y; Kaibuchi K; Takeshita A
    Circ Res; 2004 Jan; 94(1):46-52. PubMed ID: 14615290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term administration of rho-kinase inhibitor ameliorates renal damage in malignant hypertensive rats.
    Ishikawa Y; Nishikimi T; Akimoto K; Ishimura K; Ono H; Matsuoka H
    Hypertension; 2006 Jun; 47(6):1075-83. PubMed ID: 16636194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of adiponectin on cardiac β-catenin signaling pathway under angiotensin II infusion.
    Fujishima Y; Maeda N; Matsuda K; Komura N; Hirata A; Mori T; Sekimoto R; Tsushima Y; Nishizawa H; Funahashi T; Shimomura I
    Biochem Biophys Res Commun; 2014 Feb; 444(2):224-9. PubMed ID: 24462873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of osteopontin in cardiac fibrosis and remodeling in angiotensin II-induced cardiac hypertrophy.
    Matsui Y; Jia N; Okamoto H; Kon S; Onozuka H; Akino M; Liu L; Morimoto J; Rittling SR; Denhardt D; Kitabatake A; Uede T
    Hypertension; 2004 Jun; 43(6):1195-201. PubMed ID: 15123578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence of a direct cellular protective effect of Rho-kinase inhibitors on endothelin-induced cardiac myocyte hypertrophy.
    Satoh S; Kawasaki K; Ikegaki I; Asano T; Shimokawa H
    Biochem Biophys Res Commun; 2012 Jul; 424(2):338-40. PubMed ID: 22771803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppressive Effects of Glucose-Dependent Insulinotropic Polypeptide on Cardiac Hypertrophy and Fibrosis in Angiotensin II-Infused Mouse Models.
    Hiromura M; Mori Y; Kohashi K; Terasaki M; Shinmura K; Negoro T; Kawashima H; Kogure M; Wachi T; Watanabe R; Sato K; Kushima H; Tomoyasu M; Nakano Y; Yamada Y; Watanabe T; Hirano T
    Circ J; 2016 Aug; 80(9):1988-97. PubMed ID: 27375170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of fasudil, a Rho-kinase inhibitor, on myocardial preconditioning in anesthetized rats.
    Demiryürek S; Kara AF; Celik A; Babül A; Tarakçioglu M; Demiryürek AT
    Eur J Pharmacol; 2005 Dec; 527(1-3):129-40. PubMed ID: 16307738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long term Rho-kinase inhibition ameliorates endothelial dysfunction in LDL-Receptor deficient mice.
    Steioff K; Rütten H; Busch AE; Plettenburg O; Ivashchenko Y; Löhn M
    Eur J Pharmacol; 2005 Apr; 512(2-3):247-9. PubMed ID: 15840411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term inhibition of Rho-kinase suppresses left ventricular remodeling after myocardial infarction in mice.
    Hattori T; Shimokawa H; Higashi M; Hiroki J; Mukai Y; Tsutsui H; Kaibuchi K; Takeshita A
    Circulation; 2004 May; 109(18):2234-9. PubMed ID: 15096457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of fasudil on Rho-kinase and nephropathy in subtotally nephrectomized spontaneously hypertensive rats.
    Kanda T; Wakino S; Hayashi K; Homma K; Ozawa Y; Saruta T
    Kidney Int; 2003 Dec; 64(6):2009-19. PubMed ID: 14633123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.